| Back |
|
Oncology
Molecular Imaging, LLC ("OMI"), founded in
2005, focuses on Positron Emission Tomography.
Transition Capital Partners has co-developed
and invested in this dynamic healthcare service
concept with a former CEO of a portfolio company
and OMI's management team. Dan Patterson, a
Transition Capital Partners Partner notes "Transition
Capital Partners traditionally does not fund
start ups, however it does develop long-term
relationships with its business owners and
viewed this investment as an excellent working
partnership in an exciting growth area."
Visit their website |
| |
